- Home
- FTHY vs PACB Comparison
FTHY vs PACB Comparison
Compare FTHY & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FTHY | PACB |
|---|---|---|
| Founded | 2020 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 493.5M | 521.8M |
| IPO Year | 2020 | 2010 |
Fundamental Metrics
Financial Performance| Metric | FTHY | PACB |
|---|---|---|
| Price | $12.77 | $2.12 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $2.40 |
| AVG Volume (30 Days) | 121.9K | ★ 15.4M |
| Earning Date | 01-01-0001 | 11-04-2026 |
| Dividend Yield | ★ 10.93% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $93,468,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $16.01 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 3.04 |
| 52 Week Low | $12.49 | $1.07 |
| 52 Week High | $14.42 | $3.44 |
Technical Indicators
Market Signals| Indicator | FTHY | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 47.85 | 55.33 |
| Support Level | $12.51 | $1.27 |
| Resistance Level | $12.89 | $2.73 |
| Average True Range (ATR) | 0.18 | 0.28 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 73.56 | 23.92 |
Price Performance
Historical ComparisonAbout FTHY First Trust High Yield Opportunities 2027 Term Fund
FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND is a diversified, closed-end management investment company. The investment objective of the fund is to provide current income. The fund invests a majority of its managed assets in high-yield debt securities of any maturity that are rated below investment grade at the time of purchase or unrated securities. Its investment portfolio comprises corporate bonds and notes, senior floating-rate loan interests, foreign corporate bonds and notes, money market funds, and other instruments across various industries.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.